“light-sciences-oncology” Archives

Entry Author Date Location
Light Sciences Oncology Receives $1,255,674 New Financing Round 01/23/12 Seattle
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News 10/06/11 Seattle
Light Sciences Oncology Stumbles in Clinical Trial, Layoffs Loom 10/04/11 Seattle
Light Sciences Oncology Secures $6,256,000 New Funding Round 06/13/11 Seattle
Dendreon Commercial Guy Leaves, Light Sciences CEO Exits, Amgen Wins FDA OK, & More Seattle-Area Life Sciences News 11/24/10 Seattle
Light Sciences Oncology CEO Exits for New Job; Company Still Waiting for Pivotal Results 11/22/10 Seattle
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News 03/04/10 Seattle
Light Sciences Oncology Sits Tight, Awaits Key Cancer Trial Results This Summer 03/01/10 Seattle
Light Sciences Cancer Study Advances 02/25/10 Seattle
Washington Firms Raised $44.4M in 10 Venture Deals (Six Software) in November 12/09/09 Seattle
Alder’s Breakout $1B Deal, Kineta Teams With UW on Vaccines, Verathon Gets Acquired, & More Seattle-Area Life Sciences News 11/12/09 Seattle
Clearwire Closes $1.5B, Alder Scores $1B Partnership, Software Financings Are Down, & More Seattle-Area Deals News 11/10/09 Seattle
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment 11/05/09 Seattle
Light Sciences Oncology Obtains $23,300,000 New Round 11/05/09 Seattle
Cell Therapeutics Nabs $30M, Rick Klausner on Vaccines, Targeted Growth Tinkers With Algae Genes, & More Seattle-Area Life Sciences News 08/20/09 Seattle
Light Sciences Starts BPH Trial 08/18/09 Seattle
Bionavitas Pursues Algae Dream in Food Additives, Toxic Cleanup—Then Maybe Biofuel 05/18/09 Seattle
ASCO Preview: Seattle Genetics, ZymoGenetics, Trubion & Other Seattle Biotechs Offer Peeks at Cancer Drug Results 05/15/09 Seattle
HydroSense, With Plan to Conserve Water, Wins UW Environmental Business Competition 04/02/09 Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News 12/04/08 Seattle
Light Sciences Oncology Finishes Enrollment in Pivotal Clinical Trial 11/25/08 Seattle
Light Sciences Oncology Obtains $40,100,000 Series C Financing Round 07/17/08 Seattle
Light Sciences Oncology Raises $40 Million for Cancer Trials 07/15/08 Seattle
Page 1 of 1